Fact Based List:

Top Five Prescription Drugs by Revenue in 2016

Submitted by Clive Riddle on Mon, 03/20/2017 - 17:20

  1. Humira (AbbVie) $16.078 billion
  2. Harvoni (Gilead Sciences) $9.081 billion
  3. Enbrel (Amgen and Pfizer) $8.874 bllion
  4. Rituxan (Roche [Genentech] and Biogen) $8.583 billion
  5. Remicade (Johnson & Johnson and Merck) $7.829 billion

Source: Genetic Engineering & Biotechnology News
Source URL: http://www.genengnews.com/the-lists/the-top-15-best-selling-...

List Ratings:   
No votes yet
Your rating: None

Lists You Might Also Be Interested In

    Login or register to post comments